Machine learning assessment of vildagliptin and linagliptin effectiveness in type 2 diabetes: Predictors of glycemic control.
機器學習評估 vildagliptin 和 linagliptin 在 2 型糖尿病中的有效性：血糖控制的預測因子。
PLoS One 2024-08-26
Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach.
DPP-4抑制劑、GLP-1受體激動劑、SGLT-2抑制劑和磺脲類藥物對第2型糖尿病患者死亡率、心血管和腎臟結果的影響：基於網絡荟萃分析的方法。
Diabet Med 2023-11-16
Achieving Good Metabolic Control Without Weight Gain with the Systematic Use of GLP-1-RAs and SGLT-2 Inhibitors in Type 2 Diabetes: A Machine-learning Projection Using Data from Clinical Practice.
在第2型糖尿病中，透過 GLP-1-RAs 和 SGLT-2 抑制劑的系統使用，實現良好的代謝控制並避免體重增加：使用臨床實踐數據進行機器學習預測。
Clin Ther 2023-09-02
[Indicators of diabetes mellitus after liraglutide, sitagliptin/metformin, linagliptin, and sitagliptin].
liraglutide、sitagliptin/metformin、linagliptin和sitagliptin後糖尿病的指標。
Rev Med Inst Mex Seguro Soc 2023-09-09
Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study.
Pioglitazone和Linagliptin對二型糖尿病患者在二甲双胍治療下的血糖控制、脂質檔案和hs-CRP的影響：一項比較研究。
Horm Mol Biol Clin Investig 2024-02-06
Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication.
心血管疾病和2型糖尿病患者血糖化血紅素水平預測與抗糖尿病藥物相關。
Front Endocrinol (Lausanne) 2024-04-25
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
第二線口服抗糖尿病藥物在2型糖尿病患者中的比較有效性：使用常規收集的健康數據模擬目標試驗。
BMJ 2024-05-08
Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
評估達帕格醇和利那格列汀聯合治療相較於達帕格醇和維那格列汀對二型糖尿病患者在二甲双胍控制不足情況下的療效、安全性和耐受性。
Cureus 2024-05-13
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes.
糖尿病患者第二線治療中磺胺脲類藥物與新型糖尿病藥物的效果和成本效益比較。
BMJ Open Diabetes Res Care 2024-05-27
Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms.
針對2型糖尿病中對glucagon-like peptide-1療法反應的臨床、基因組和蛋白質組標記的計算方法：使用機器學習算法的探索性分析。
Diabetes Metab Syndr 2024-07-27
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.
第二線降血糖藥物對心血管結果的比較效果：LEGEND-T2DM的多國聯合分析。
J Am Coll Cardiol 2024-08-28